- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00707694
The Longevity Genes in Founder Populations Project
December 13, 2023 updated by: Albert Einstein College of Medicine
Searching for Longevity Genes in the Historically Unique Ashkenazi Jewish Population
We believe extreme longevity is due to specific genes which function to delay aging and prevent disease.
The purpose of our research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Deborah Davidson, MBA
- Phone Number: 718-430-3237
- Email: longevity@aecom.yu.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118-2526
- Recruiting
- Boston University Medical Center
-
Contact:
- Thomas Perls, MD, MPH
- Phone Number: 617-638-7207
-
-
New York
-
New York, New York, United States, 10065
- Recruiting
- Weill Cornell Medical College
-
Contact:
- Todd Evans, MD
- Phone Number: 646-962-8200
-
New York, New York, United States
- Recruiting
- Private Homes
-
Contact:
- Wanda I Guzman, BA
- Phone Number: 718-430-3838
- Email: WANDA.GUZMAN@EINSTEINMED.EDU
-
Riverdale, New York, United States, 10471
- Recruiting
- Hebrew Home Riverdale
-
Contact:
- Charlotte Dell, LMSW
- Phone Number: 718-581-1139
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
63 years and older (Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Ashkenazi Jews:
Ages 95 and older, their offspring and control group with no family history of longevity.
Description
Inclusion Criteria:
- Ashkenazi Jewish, age 95+,
- Offspring of person age 95+,
- Offspring of parents who died age 70 or younger.
Exclusion Criteria:
- Non-Ashkenazis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Probands
Ashkenazi Jews ages 95 and older
|
Offspring
Ashkenazi Jewish offspring of Ashkenazi Jewish parent(s) who lived to at least the age of 95
|
Controls
Ashkenazi Jewish people with no family history of longevity
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Nir Barzilai, MD, Albert Einstein College of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 1998
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Study Registration Dates
First Submitted
June 27, 2008
First Submitted That Met QC Criteria
June 30, 2008
First Posted (Estimated)
July 1, 2008
Study Record Updates
Last Update Posted (Estimated)
December 19, 2023
Last Update Submitted That Met QC Criteria
December 13, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1998-125
- 2U19AG056278-07A1 (U.S. NIH Grant/Contract)
- 3U19AG056278-06S1 (U.S. NIH Grant/Contract)
- P01AG021654 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Extreme Longevity
-
Leiden University Medical CenterJacobijn Gussekloo, Prof. dr.; Simon P. Mooijaart, Prof. dr.RecruitingAging | Extreme Longevity | Longevity | Familial LongevityNetherlands
-
Rambam Health Care CampusIsrael Science FoundationCompleted
-
Flavia Pardo Salata NahsanCompletedDefinitive Restorations, Longevity
-
University of TeramoDAngelinoCompletedDiet Habit | Fasting | Activity, Motor | LONGEVITY 1Italy
-
Federal University of PelotasUnknownDental Restoration Failure | Esthetics, Dental | Dental Restorations LongevityBrazil
-
Universitair Ziekenhuis BrusselCompleted
-
Children's Hospital Medical Center, CincinnatiUniversity of CincinnatiTerminatedExtreme ImmaturityUnited States
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...University of Milan; Italian Air Force; A-Tono; Ministry of Defense, ItalyRecruitingCardiovascular Risk Factor | Discogenic Pain | Neuroplasticity | Epigenetic Changes | Stress Physiological | Space Maintenance | Oxidative Injury | LONGEVITY 1 | NGSItaly
-
Center for Strategic Planning, of the Federal Medical...Pirogov Russian National Research Medical UniversityRecruitingFrailty | Aging | Aging Disorder | Age-related Cognitive Decline | LONGEVITY 1Russian Federation
-
University of UlmCharite University, Berlin, Germany; University of Leipzig; University of Witten... and other collaboratorsActive, not recruiting